Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Am Dent Assoc ; 139(8): 1080-93, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18682623

RESUMEN

BACKGROUND: The authors conducted two multicenter, randomized, double-blinded, controlled Phase III clinical trials to study the efficacy and safety of phentolamine mesylate (PM) in shortening the duration and burden of soft-tissue anesthesia. The study involved 484 subjects who received one of four commercially available local anesthetic solutions containing vasoconstrictors for restorative or scaling procedures. METHODS: On completion of the dental procedure, subjects randomly received a PM or a sham injection (an injection in which a needle does not penetrate the soft tissue) in the same site as the local anesthetic injection. The investigators measured the duration of soft-tissue anesthesia by using standardized lip- and tongue-tapping procedures every five minutes for five hours. They also evaluated functional measures and subject-perceived altered function, sensation, appearance and safety. RESULTS: Median recovery times in the lower lip and tongue for subjects in the PM group were 70 minutes and 60 minutes, respectively. Median recovery times in the lower lip and tongue for subjects in the sham group were 155 minutes and 125 minutes, respectively. Upper lip median recovery times were 50 minutes for subjects in the PM group and 133 minutes for subjects in the sham group. These differences were significant (P < .0001). Recovery from actual functional deficits and subject-perceived altered function, sensation and appearance also showed significant differences between the PM and the sham groups. CONCLUSIONS: PM was efficacious and safe in reducing the duration of local anesthetic- induced soft-tissue numbness and its associated functional deficits. CLINICAL IMPLICATIONS: Clinicians can use PM to accelerate reversal of soft-tissue anesthesia and the associated functional deficits.


Asunto(s)
Antagonistas Adrenérgicos alfa/uso terapéutico , Anestesia Dental , Anestésicos Locales/antagonistas & inhibidores , Restauración Dental Permanente , Raspado Dental , Fentolamina/uso terapéutico , Adolescente , Adulto , Anciano , Periodo de Recuperación de la Anestesia , Carticaína/antagonistas & inhibidores , Niño , Epinefrina/antagonistas & inhibidores , Femenino , Humanos , Lidocaína/antagonistas & inhibidores , Labio/efectos de los fármacos , Labio/fisiología , Masculino , Mepivacaína/antagonistas & inhibidores , Persona de Mediana Edad , Nordefrin/antagonistas & inhibidores , Prilocaína/antagonistas & inhibidores , Seguridad , Sensación/efectos de los fármacos , Sensación/fisiología , Factores de Tiempo , Lengua/efectos de los fármacos , Lengua/fisiología , Resultado del Tratamiento , Vasoconstrictores/antagonistas & inhibidores
2.
Acta Anaesthesiol Scand ; 19(5): 377-83, 1975.
Artículo en Inglés | MEDLINE | ID: mdl-1211077

RESUMEN

In the present investigation it is shown that administration of polyphloretin phosphate (PPP) together with local anaesthetics decreased the duration of infiltration anaesthesia in guinea-pigs. Furthermore, it is shown that in infiltration anaesthesias the local anaesthetic effect was terminated within a few minutes by administration of PPP. In experiments with high- and low-molecular fractions of PPP, the "anti-local anaesthetic" effect of PPP was not due to the antiprostaglandin activity of PPP. There was no effect of PPP on the duration of the nerve-blocking activity of mepivacaine in rats. Neither did the administration of PPP influence the toxic effects of mepivacaine in rabbits.


Asunto(s)
Anestesia Local , Bupivacaína/antagonistas & inhibidores , Lidocaína/antagonistas & inhibidores , Mepivacaína/antagonistas & inhibidores , Floretina/análogos & derivados , Fosfato de Polifloretina/farmacología , Prilocaína/antagonistas & inhibidores , Animales , Bupivacaína/metabolismo , Femenino , Cobayas , Lidocaína/metabolismo , Masculino , Mepivacaína/metabolismo , Mepivacaína/toxicidad , Bloqueo Nervioso , Prilocaína/metabolismo , Conejos , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...